KLF2 Mediated HIF-1 Regulation and Macrophage Activation
KLF2 介导的 HIF-1 调节和巨噬细胞激活
基本信息
- 批准号:8327773
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-06 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAtherosclerosisAwardDevelopmentDiseaseFoundationsFundingGene ExpressionGoalsHypoxiaHypoxia Inducible FactorInflammationInflammatory ResponseInstructionMacrophage ActivationMatrix MetalloproteinasesMediatingMolecularMolecular GeneticsPathogenesisPathologicPhasePhysiologicalPlayProductionRegulationResearch PersonnelResolutionRoleSepsisTissuesTrainingTranslatingUnited States National Institutes of Healthbasecytokinein vivoinhibitor/antagonistloss of functionmacrophagenovelnovel strategiesresponsetumor
项目摘要
The inflammatory response is critical in regulating a broad spectrum of physiologic and pathologic states.
The tissue macrophage is a central regulator of this response - from initiation to resolution o inflammation.
Recent studies have identified Hypoxia-inducible Factor 1alpha(HlF-1 alpha) as a key regulator of
macrophage activation function. Using a combination of gain- and loss-of-function approaches, the PI has
identified KLF2 as a novel endogenous regulator of HlF-1 alpha expression and function. Specifically, our
studies show that (1) KLF2 inhibits HlF-1 expression and transcriptional activity; (2) altering KLF2
expression affects HIF-lalpha target gene expression, ATP production, cytokine/MMP expression, and
bacterial/tumoricidal activity of macrophages. In this proposal a cornbination of molecular and genetic
approaches will be undertaken (1) to determine the molecular basis for KLF2-mediated inhibition of
HIF-lalpha expression, (2) to evaluate the effect of altering KLF2 levels on hypoxia or LPS mediated
activation of macrophages, and (3) to assess the effect of altering KLF2 levels on hypoxia or LPS-mediated
macrophage function in vivo. These studies will provide the foundation for the applicant to achieve his longterm
goals of translating basic mechanisms of inflammation toward the development of novel therapies.
Continuing support of this project via a ROO award would play a pivotal and requisite role in the Pi's
development into an independent investigator. The Pl has completed requisite additional training during the
K99 phase of award and is now transiting toward becoming an NIH-funded independent investigator with
adequate institutional support.
炎症反应在调节多种生理和病理状态方面起着关键作用。
组织巨噬细胞是这种反应的中心调节器--从启动到消退炎症。
最近的研究发现,低氧诱导因子1α(HLF-1α)是一种关键的调节因子。
巨噬细胞激活功能。结合使用增益和损失函数的方法,PI具有
KLF2是一种新的HLF-1α表达和功能的内源性调节因子。具体地说,我们的
研究表明:(1)KLF2抑制HLF-1的表达和转录活性;(2)改变KLF2
表达影响HIF-α靶基因表达、ATP产生、细胞因子/基质金属蛋白酶表达,以及
巨噬细胞的杀菌/杀瘤活性。在这项建议中,分子和遗传的结合
将采取以下方法:(1)确定KLF2介导抑制KLF2的分子基础
HIF-α的表达,(2)评价KLF2水平改变对缺氧或内毒素介导的影响
巨噬细胞的激活,以及(3)评估改变KLF2水平对缺氧或内毒素介导的影响
巨噬细胞在体内的功能。这些研究将为申请人实现其长期目标奠定基础。
将炎症的基本机制转化为新疗法的开发的目标。
通过Roo奖继续支持该项目将在PI中发挥关键和必要的作用
发展成为独立的调查员。在此期间,公共部门已完成必要的额外培训。
K99阶段的奖励,现在正在过渡到成为NIH资助的独立调查员
有足够的制度支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ganapati Holanagadde Mahabaleshwar其他文献
Ganapati Holanagadde Mahabaleshwar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ganapati Holanagadde Mahabaleshwar', 18)}}的其他基金
Role of KLF6 in macrophage lipid homeostasis and atherogenesis
KLF6 在巨噬细胞脂质稳态和动脉粥样硬化形成中的作用
- 批准号:
9266485 - 财政年份:2015
- 资助金额:
$ 24.9万 - 项目类别:
KLF2 Mediated HIF-1 Regulation and Macrophage Activation
KLF2 介导的 HIF-1 调节和巨噬细胞激活
- 批准号:
8307111 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
KLF2 Mediated HIF-1 Regulation and Macrophage Activation
KLF2 介导的 HIF-1 调节和巨噬细胞激活
- 批准号:
8505528 - 财政年份:2011
- 资助金额:
$ 24.9万 - 项目类别:
KLF2 Mediated HIF-1 Regulation and Macrophage Activation
KLF2 介导的 HIF-1 调节和巨噬细胞激活
- 批准号:
7713630 - 财政年份:2009
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:














{{item.name}}会员




